default image

Urologie

Information and services of the department

  • Number of inpatient cases: 270

Zusätzlich wurden 32 Hybrid-DRG-Fälle erbracht: L17N 4 L20M 19 L20N 9

Services search (in the department)


Illness Number of cases
Hyperplasia of prostate (N40) 36
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 33
Malignant neoplasm of prostate (C61) 30
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 17
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) 17
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) 14
Neoplasm of uncertain or unknown behaviour of male genital organs - Neoplasm of uncertain behavior of prostate (D40.0) 10
Other disorders of urinary system - Urinary tract infection site not specified (N39.0) 10
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5) 8
Other disorders of bladder - Bladder-neck obstruction (N32.0) 6
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 149
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 90
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 42
Dilatation of the ureters during an operation or endoscopy (5-560.2) 41
(5-98k.0) 38
Insertion, exchange or removal of a ureteral stent (8-137.00) 32
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 31
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 31
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) 27
Injection or administration of medicines into the urinary bladder (8-132.2) 25

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung 0
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Number Group
52 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
33 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
29 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
No. Training in other healing professions Comment
HB19 Nursing professionals Dreijährig examiniertes Pflegepersonal
HB17 Auxiliary nurse (m/f) Einjährig examiniertes Pflegepersonal

Herr Michael Hofmann

Klinikgeschäftsführer

Phone: 09372 -700-1000
Mail: ed.tiehdnuseg-soileh@2nnamfoH.leahciM

Frau Natascha Breunig

Qualitätsmanagement

Phone: 09372 -700-1065
Mail: ed.tiehdnuseg-soileh@hcabnelrE.gnunieM

Frau Natascha Breunig

Qualitätsmanagementbeauftragte

Phone: 09372 -700-1065
Mail: ed.tiehdnuseg-soileh@ginuerB.ahcsataN

Ärztlicher Direktor / Herr Chefarzt Dr. Michael Weberpals

Vorsitzender

Phone: 09372 -700-1920
Mail: ed.tiehdnuseg-soileh@slaprebeW.leahciM

Frau Susana Höll Jordao

kommissarische Leitung Apotheke

Phone: 0611 -43-3515
Mail: ed.tiehdnuseg-soileh@oadroJlleoH.anasuS